Arkolith/Insider Trading/HARP/Form 4

Merck & Co., Inc.

10% OwnerHarpoon Therapeutics, Inc. (HARP) · full profile →Form 4 · filed Mar 11, 2024
Net Buying
Open-Market Buys
$492.1M
Open-Market Sells
$0
Net Open-Market Flow
$492.1M
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 11, 2024Buy(P)21.4M$23.00$492.1M1K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-029165) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML